1 Li Q,Guan X,Wu P,et al.Early transmission dynamics in Wuhan,China,of novel coronavirus-infected pneumonia[J].N Engl J Med,2020[Epub ahead of print]. 2 郑荣寿,孙可欣,张思维,等.2015年中国恶性.肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28. 3 Siegel RL,Miller KD,Jemal A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30. 4 Liang W,Guan W,Chen R,et al.Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China[J].Lancet Oncol,2020,2045(20):30096-20096. 5 Xia Y,Jin R,Zhao J,et al.Risk of COVID-19 for cancer patients[J].Lancet Oncol,2020,2045(20)30150-30159. 6 Wang HP,Zhang L.Risk of COVID-19 for cancer patients[J].Lancet Oncol,2020,2045(20):30149-30142. 7 陈衍智,李萍萍.肿瘤性发热的诊治进展[J].中国肿瘤临床,2012,39(6):355-357. 8 林铃,李太生.国家卫生健康委员会《新型冠状病毒感染的肺炎诊疗方案(试行第五版)》解读[J].中华医学杂志,2020,100(1):1. 9 Maresso KC,Tsai KY,Brown PH,et al.Molecular cancer prevention:current status and future directions[J].CA Cancer J Clin,2015,65(5):345-383. 10 Tan CS,Gilligan D,Pacey S.Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer[J].Lancet Oncol,2015,16(9):447-459. 11 Levitzki A.Tyrosine kinase inhibitors:views of selectivity,sensitivity,and clinical performance[J].Annu Rev Pharmacol Toxicol,2013,53:161-185. 12 Ganesh K,Stadler ZK,Cercek A,et al.Immunotherapy in colorectal cancer:rationale,challenges and potential[J].Nat Rev Gastroenterol Hepatol,2019,16(6):361-375. |